These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16878474)

  • 1. Occupational lyssavirus risks and post-vaccination monitoring.
    Brookes SM; Fooks AR
    Dev Biol (Basel); 2006; 125():165-73. PubMed ID: 16878474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of rabies vaccine strains to elicit cross-neutralising antibodies.
    Brookes SM; Healy DM; Fooks AR
    Dev Biol (Basel); 2006; 125():185-93. PubMed ID: 16878476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
    Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
    Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
    Müller T; Selhorst T; Burow J; Schameitat A; Vos A
    Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure rabies booster vaccinations: a literature review.
    Morris J; Crowcroft NS
    Dev Biol (Basel); 2006; 125():205-15. PubMed ID: 16878478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian bat lyssavirus infection in three fruit bats from north Queensland.
    Speare R; Skerratt L; Foster R; Berger L; Hooper P; Lunt R; Blair D; Hansman D; Goulet M; Cooper S
    Commun Dis Intell; 1997 May; 21(9):117-20. PubMed ID: 9145563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains.
    Malerczyk C; Selhorst T; Tordo N; Moore S; Müller T
    Vaccine; 2009 Aug; 27(39):5320-5. PubMed ID: 19615958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rabies biologics against new lyssaviruses from Eurasia.
    Hanlon CA; Kuzmin IV; Blanton JD; Weldon WC; Manangan JS; Rupprecht CE
    Virus Res; 2005 Jul; 111(1):44-54. PubMed ID: 15896401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
    Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
    Servat A; Wasniewski M; Cliquet F
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses.
    Brookes SM; Parsons G; Johnson N; McElhinney LM; Fooks AR
    Vaccine; 2005 Jul; 23(32):4101-9. PubMed ID: 15964478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic response to rabies pre-exposure vaccination in persons with potential occupational exposure in Singapore.
    Lim PL; Barkham TM
    Int J Infect Dis; 2010 Jun; 14(6):e511-3. PubMed ID: 20018545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1.
    Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V
    Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.
    Weir DL; Coggins SA; Vu BK; Coertse J; Yan L; Smith IL; Laing ED; Markotter W; Broder CC; Schaefer BC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veterinary surgeon's guide to Australian bat lyssavirus.
    Thompson GK
    Aust Vet J; 1999 Nov; 77(11):710-2. PubMed ID: 10685161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination.
    Morris J; Crowcroft NS; Fooks AR; Brookes SM; Andrews N
    Hum Vaccin; 2007; 3(5):165-70. PubMed ID: 17786037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyssavirus infection: 'low dose, multiple exposure' in the mouse model.
    Banyard AC; Healy DM; Brookes SM; Voller K; Hicks DJ; Núñez A; Fooks AR
    Virus Res; 2014 Mar; 181():35-42. PubMed ID: 24380842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies and African bat lyssavirus encephalitis and its prevention.
    Warrell M
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S47-52. PubMed ID: 20801003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
    Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.